A Buyer’s Checklist for Clinical Trial Data Analytics: Seven Questions That Separate a Demo From a Daily Tool

The best demo can hide the operational details that matter after week one. When you evaluate a clinical trial data analytics workspace, look past the dashboard and ask how the system handles versioned data cuts, document search, blinding grants, audit trails, study-level roles and code transparency. The goal is not to find the longest feature list. It is to find a workspace your study team can defend when someone asks, “Which cut did you review, who could see it, and how do you know?”

1. Data-Cut Versioning: Can You Prove Which Cut You Reviewed?

A clinical study is not a single, static folder. Data arrive in cuts, and every review, issue and chart should point back to the right cut. Ask whether every upload becomes a new revision with its own checksum. Ask whether the previous revision is overwritten or preserved. Ask whether each person can choose which cut they are viewing, so a statistician can inspect an earlier cut while a data manager works on the current one without confusion. The stronger answer is that data cuts are kept in order, each upload is a new revision with its own checksum, and nothing is overwritten.

Versioning should not stop at the file name. Ask how the workspace compares cuts side by side. Can you open a dataset, filter to the subjects you care about, and switch on compare mode to see what changed between cuts? Can you do that for a dataset, a document or an output, or only for one file type? Also ask how a note or issue behaves when the cut changes. A comment attached to “the lab data” is not enough. You want notes and issues attached to the exact form, field, row or document page they are about.

Ask for a live walk-through using your own study’s file structure—EDC data, SDTM, ADaM, define.xml, lab data, protocols, SAPs and TFL outputs. A workspace should group files by source, not force your team into a new filing convention. If the versioning model cannot survive that first real upload, keep asking questions.

2. Document Search: Can You Find the Sentence Behind the Dataset?

Protocols, SAPs and annotated CRFs are not background reading; they are the rules behind the data. A page-by-page document search is therefore a practical requirement, not a nice-to-have. Ask whether search is limited to file names or whether it searches inside documents. Ask whether results take you to the exact page, and whether that page sits next to the data it describes. In a strong workspace, protocols, SAPs and annotated CRFs are searchable page by page, next to the data they describe.

Then test the boundary between search and blinding. If a document page contains unblinded content, search should not leak it to someone without the right grant. Ask whether hidden content is excluded from results, snippets and page previews, or only from the document view. Ask whether a viewer, collaborator or owner can see search results for a study they do not belong to. The answer should be no. People should see only the studies they belong to, with roles that reflect their responsibilities.

3. Blinding Grants: Is Unblinding a Separate, Visible Permission?

Blinding is not a role checkbox. Ask how unblinded content is separated from the rest of the workspace. Does a person need a separate grant to see unblinded files, records and search results? Without that grant, are those items hidden regardless of someone’s study role? A credible answer is specific: unblinded content needs its own grant, and without it, those files, records and search results stay hidden, whatever a person’s role.

Ask who can grant unblinding, how the grant is recorded, and where the change appears in the audit trail. Ask whether the grant is study-specific or broad across studies. Ask whether it can be reviewed and retired without deleting the historical record. A buyer should also ask for a demonstration: log in as a collaborator without the unblinding grant, search for a term that appears only in an unblinded document, and confirm that no snippet, page preview or dataset row appears.

4. Audit Trails and Study-Level Roles: Can You Reconstruct Who Did What?

An audit trail is only useful if it captures the events that change access and interpretation. Ask whether changes to membership, roles, unblinding and records are written to an append-only log. Ask whether records are truly deleted or simply retired or superseded. If files are removed from view, can you still find the prior revision? The benchmark should be simple: nothing is deleted, records are retired or superseded, every file revision is kept, and changes to membership, roles, unblinding and records are written to an append-only log.

Study-level roles need the same scrutiny. Ask whether access is assigned by study, and whether the available roles are clear enough to separate viewing from collaboration and ownership. Can a viewer see only what they need? Can a collaborator attach notes and issues to a form, field, row or document page? Can an owner manage membership without seeing every study in the account? The workspace should let people see only the studies they belong to, as a viewer, collaborator or owner.

Do not ignore the surrounding account model. Ask whether each customer runs in a separate AWS account with its own database and storage. Ask how sign-in works and how long sessions last. A strong answer includes emailed-code sign-in and a 30-minute session timeout after inactivity. Those details are not glamorous, but they are controls a study team can explain to a reviewer.

5. Code Transparency and the Question Tool: Can a Statistician Check the Work?

Plain-language questions are only useful if the answer can be checked. Ask what happens when someone asks about enrolment, adverse events, discontinuation or a lab change. Does the tool return a number and a chart and stop there, or does it show the code that produced the result? In a transparent workspace, the assistant writes Python, runs it on the study’s data and shows both the code and the result. A statistician can then inspect the logic rather than trusting an answer box.

Ask where that code runs. Does it run in an isolated sandbox with read-only, short-lived access to one study? Can it reach another study or the wider account? Ask whether the code is shown with every answer, and whether results include the tables and charts that made the answer. Ask for a demonstration with a realistic question, then ask to see the code, the output and the scope of access.

Finally, ask how the question tool is tested before it reaches a study. A serious buyer should hear that it is benchmarked on real clinical analysis tasks with known right answers and planted data traps before use. Ask whether the same instructions, tools and sandbox are used in testing as in the product. Ask whether a new version or a change to instructions is benchmarked again before it reaches a study. Limora offers demos on request—a good moment to test these points with your own files.